WEKO3
アイテム
{"_buckets": {"deposit": "880450c2-e63b-472d-8188-d67c95a26c22"}, "_deposit": {"created_by": 3, "id": "2234", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "2234"}, "status": "published"}, "_oai": {"id": "oai:toyama.repo.nii.ac.jp:00002234", "sets": ["442"]}, "author_link": ["132557", "6175", "6178", "132556", "132555", "132554"], "item_2_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2005-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "626", "bibliographicPageStart": "621", "bibliographicVolumeNumber": "45", "bibliographic_titles": [{"bibliographic_title": "Neurologia medico-chirurgica : 神経外科"}]}]}, "item_2_description_15": {"attribute_name": "フォーマット", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Inflammatory reaction is very important for formation of the neomembrane of chronic subdural hematoma (CSDH). The present study evaluated medical treatment with the platelet-activating factor receptor antagonist, etizolam, for the resolution of CSDH, and the factors indicating surgery or conservative therapy. Alternate patients were assigned to the etizolam group or control group without medical treatment. Patients in the etizolam group received 3.0mg etizolam per day for 14 days. A total of 53 patients were followed up for at least 6 months. Univariate analysis of differences in demographic characteristics, clinical findings, and initial computed tomography (CT) findings, and multiple logistic regression analysis of the relationship between etizolam treatment and requirement for surgery using age, sex, low density of hematoma on CT, and paresis as confounders were performed. Etizolam treatment (adjusted odds ratio [OR] 0.156, 95% confidence interval [CI] 0.024-0.999, p=0.049) was negatively correlated with requirement for surgery. Low density of hematoma (adjusted OR 0.125, 95% CI 0.019-0.846, p=0.033) was found to be an independent negative predictor, and paresis as an initial symptom (adjusted OR 6.35, 95% CI 1.04-38.7, p=0.045) was an independent positive predictor of requirement for surgery. Etizolam administration can promote the resolution of CSDH, especially at the stage of hygroma appearing as low density on CT. Surgery is recommended if the patient presents with paresis.", "subitem_description_type": "Abstract"}]}, "item_2_description_40": {"attribute_name": "資源タイプ(DSpace)", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本脳神経外科学会"}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "rights: 本文データは日本脳神経外科学会の許諾に基づきCiNiiから複製したものであ"}]}, "item_2_source_id_10": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00358613", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_8": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "04708105", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Hirashima, Yutaka"}], "nameIdentifiers": [{"nameIdentifier": "132554", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kurimoto, Masanori"}], "nameIdentifiers": [{"nameIdentifier": "132555", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nagai, Shoichi"}], "nameIdentifiers": [{"nameIdentifier": "132556", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hori, Emiko"}], "nameIdentifiers": [{"nameIdentifier": "132557", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Origasa, Hideki"}], "nameIdentifiers": [{"nameIdentifier": "6178", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "1000020245038", "nameIdentifierScheme": "CiNii ID", "nameIdentifierURI": "http://ci.nii.ac.jp/nrid/1000020245038"}, {"nameIdentifier": "20245038", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000020245038"}]}, {"creatorNames": [{"creatorName": "Endo, Shunro"}], "nameIdentifiers": [{"nameIdentifier": "6175", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "1000070125269", "nameIdentifierScheme": "CiNii ID", "nameIdentifierURI": "http://ci.nii.ac.jp/nrid/1000070125269"}, {"nameIdentifier": "70125269", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000070125269"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2016-02-15"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "shinkeigeka05-621.pdf", "filesize": [{"value": "594.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 594400.0, "url": {"label": "shinkeigeka05-621.pdf", "url": "https://toyama.repo.nii.ac.jp/record/2234/files/shinkeigeka05-621.pdf"}, "version_id": "217a140f-0eb3-4212-a483-f13c2fa94447"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "chronic subdural hematoma", "subitem_subject_scheme": "Other"}, {"subitem_subject": "computed tomography", "subitem_subject_scheme": "Other"}, {"subitem_subject": "etizolam", "subitem_subject_scheme": "Other"}, {"subitem_subject": "platelet-activating factor receptor antagonist", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma : A Prospective Study to Investigate Use as Conservative Therapy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma : A Prospective Study to Investigate Use as Conservative Therapy"}]}, "item_type_id": "2", "owner": "3", "path": ["442"], "permalink_uri": "http://hdl.handle.net/10110/2018", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-01-30"}, "publish_date": "2008-01-30", "publish_status": "0", "recid": "2234", "relation": {}, "relation_version_is_last": true, "title": ["Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma : A Prospective Study to Investigate Use as Conservative Therapy"], "weko_shared_id": 3}
Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma : A Prospective Study to Investigate Use as Conservative Therapy
http://hdl.handle.net/10110/2018
http://hdl.handle.net/10110/201883bb0efc-d203-4d01-b6e8-5a472594ed81
名前 / ファイル | ライセンス | アクション |
---|---|---|
shinkeigeka05-621.pdf (594.4 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-01-30 | |||||
タイトル | ||||||
タイトル | Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma : A Prospective Study to Investigate Use as Conservative Therapy | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | chronic subdural hematoma | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | computed tomography | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | etizolam | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | platelet-activating factor receptor antagonist | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Hirashima, Yutaka
× Hirashima, Yutaka× Kurimoto, Masanori× Nagai, Shoichi× Hori, Emiko× Origasa, Hideki× Endo, Shunro |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Inflammatory reaction is very important for formation of the neomembrane of chronic subdural hematoma (CSDH). The present study evaluated medical treatment with the platelet-activating factor receptor antagonist, etizolam, for the resolution of CSDH, and the factors indicating surgery or conservative therapy. Alternate patients were assigned to the etizolam group or control group without medical treatment. Patients in the etizolam group received 3.0mg etizolam per day for 14 days. A total of 53 patients were followed up for at least 6 months. Univariate analysis of differences in demographic characteristics, clinical findings, and initial computed tomography (CT) findings, and multiple logistic regression analysis of the relationship between etizolam treatment and requirement for surgery using age, sex, low density of hematoma on CT, and paresis as confounders were performed. Etizolam treatment (adjusted odds ratio [OR] 0.156, 95% confidence interval [CI] 0.024-0.999, p=0.049) was negatively correlated with requirement for surgery. Low density of hematoma (adjusted OR 0.125, 95% CI 0.019-0.846, p=0.033) was found to be an independent negative predictor, and paresis as an initial symptom (adjusted OR 6.35, 95% CI 1.04-38.7, p=0.045) was an independent positive predictor of requirement for surgery. Etizolam administration can promote the resolution of CSDH, especially at the stage of hygroma appearing as low density on CT. Surgery is recommended if the patient presents with paresis. | |||||
書誌情報 |
Neurologia medico-chirurgica : 神経外科 巻 45, 号 12, p. 621-626, 発行日 2005-12 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 04708105 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00358613 | |||||
権利 | ||||||
権利情報 | rights: 本文データは日本脳神経外科学会の許諾に基づきCiNiiから複製したものであ | |||||
フォーマット | ||||||
内容記述タイプ | Other | |||||
内容記述 | application/pdf | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
出版者 | ||||||
出版者 | 日本脳神経外科学会 | |||||
資源タイプ(DSpace) | ||||||
内容記述タイプ | Other | |||||
内容記述 | Article |